Trends in Molecular Medicine Journal Impact Factor & Information

Publisher: Elsevier

Journal description

Trends in Molecular Medicine's objective is to facilitate communication between groups of highly trained professionals with distinct backgrounds and skills, whose common goals are to understand and explain the molecular basis of disease with a view to new clinical practice. Trends in Molecular Medicine is a resource for students and professionals alike, who have information needs that transcend the traditional clinical or scientific categorisation. Trends in Molecular Medicine includes review articles on the genetic basis of disease, but 'molecular' does not only mean DNA. The diagnostic role of genetic processes is clear, but major benefits in health and disease are also provided by other molecules: enzymes, antibiotics, hormones, metals, carbohydrates, lipids, vitamins, synthetic organic and inorganic polymers. Such benefits are discussed and evaluated by Trends in Molecular Medicine. Furthermore 'Medicine' involves a vital societal element; molecular intervention raises controversial ethical, legal and financial issues. All these issues are addressed in Trends in Molecular Medicine in a style that builds on 25 years' experience of publishing the Trends Journals.

Current impact factor: 10.11

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 10.11
2012 Impact Factor 9.571
2011 Impact Factor 10.355
2010 Impact Factor 10.308
2009 Impact Factor 11.049
2008 Impact Factor 9.621
2007 Impact Factor 7.244
2006 Impact Factor 5.864
2005 Impact Factor 5.505
2004 Impact Factor 7.497
2003 Impact Factor 9.848
2002 Impact Factor 7.162
2001 Impact Factor

Impact factor over time

Impact factor
Year

Additional details

5-year impact 10.14
Cited half-life 5.40
Immediacy index 1.49
Eigenfactor 0.02
Article influence 3.84
Website Trends in Molecular Medicine website
Other titles Trends in molecular medicine (Online)
ISSN 1471-4914
OCLC 45949985
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Elsevier

  • Pre-print
    • Author cannot archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • On authors personal or authors institutions server
    • Published source must be acknowledged
    • Must link to journal home page
    • Publisher's version/PDF cannot be used
    • 'Elsevier (Cell Press)' is an imprint of 'Elsevier'
  • Classification
    ​ blue

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Placebos are indispensable controls in randomized clinical trials (RCTs), and placebo responses significantly contribute to routine clinical outcomes. Recent neurophysiological studies reveal neurotransmitter pathways that mediate placebo effects. Evidence that genetic variations in these pathways can modify placebo effects raises the possibility of using genetic screening to identify placebo responders and thereby increase RCT efficacy and improve therapeutic care. Furthermore, the possibility of interaction between placebo and drug molecular pathways warrants consideration in RCT design. The study of genomic effects on placebo response, 'the placebome', is in its infancy. Here, we review evidence from placebo studies and RCTs to identify putative genes in the placebome, examine evidence for placebo-drug interactions, and discuss implications for RCTs and clinical care. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Trends in Molecular Medicine 04/2015; in press(5). DOI:10.1016/j.molmed.2015.02.009
  • [Show abstract] [Hide abstract]
    ABSTRACT: Breastfeeding may be the biological norm, but in Western culture it is not the social norm. Although intention to breastfeed is high, new mothers emerge into a formula-feeding culture where formula milk appears as the solution to the public harassment, negative attitudes, and lack of support that breastfeeding women face. Copyright © 2014. Published by Elsevier Ltd.
    Trends in Molecular Medicine 02/2015; 21(2):57 - 59. DOI:10.1016/j.molmed.2014.11.006
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sophistication in DNA and RNA sequencing technology is unraveling the tremendous genetic and molecular complexity of human cancer. However, the rate at which this knowledge is being translated into patient care is too slow. To this end, we have designed and implemented a new translational platform, 'The Co-Clinical Trial Project', where data obtained in genetically engineered mouse models (GEMMs) of human cancer treated with protocols identical to those of ongoing clinical trials or with therapies already established in patients serve to rapidly: (i) stratify patients in terms of response and resistance on the basis of genetic and molecular criteria; (ii) identify mechanisms responsible for tumor resistance; and (iii) evaluate the effectiveness of drug combinations to overcome such resistance based on mechanistic understanding. Copyright © 2014. Published by Elsevier Ltd.
    Trends in Molecular Medicine 11/2014; 21(1). DOI:10.1016/j.molmed.2014.10.008
  • [Show abstract] [Hide abstract]
    ABSTRACT: Small intestine bacterial overgrowth (SIBO) occurs when colonic quantities of commensal bacteria are present in the small bowel. SIBO is associated with conditions of disrupted GI motility leading to stasis of luminal contents. Recent data show that SIBO is also found in children living in unsanitary conditions that do not have access to clean water. SIBO leads to impaired micronutrient absorption and increased GI permeability, both of which may contribute to growth stunting in children. SIBO also disrupts mucosal immunity and has been implicated in oral vaccination underperformance and the development of celiac disease. SIBO in the setting of the impoverished human habitat may be an under recognized cause of pediatric morbidity and mortality in the developing world.
    Trends in Molecular Medicine 11/2014; 21(1). DOI:10.1016/j.molmed.2014.11.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: miRNAs are small noncoding RNAs known to post-transcriptionally regulate gene expression. miRNAs are expressed in the heart where they regulate multiple pathophysiological processes. The discovery of stable cardiac miRNAs in the bloodstream has also motivated the investigation of their potential as biomarkers. This review gathers the current knowledge on the use of miRNAs as novel biomarkers to improve risk stratification, diagnosis, and prognosis of patients with myocardial infarction. In the rapidly evolving era of biomarkers, the potential of miRNAs as promising tools to move personalized medicine a step forward is discussed. Copyright © 2014 Elsevier Ltd. All rights reserved.
    Trends in Molecular Medicine 11/2014; 20(12). DOI:10.1016/j.molmed.2014.10.006
  • [Show abstract] [Hide abstract]
    ABSTRACT: The central role of vascular endothelial growth factor (VEGF) signaling in regulating normal vascular development and pathological angiogenesis has been documented in multiple studies. Ocular anti-VEGF therapy is highly effective for treating a subset of patients with blinding eye disorders such as diabetic retinopathy and neovascular age-related macular degeneration (AMD). However, chronic VEGF suppression can lead to adverse effects associated with poor visual outcomes due to the loss of prosurvival and neurotrophic capacities of VEGF. In this review, we discuss emerging evidence for immune-related mechanisms that regulate ocular angiogenesis in a VEGF-independent manner. These novel molecular and cellular pathways may provide potential therapeutic avenues for a multitarget strategy, preserving the neuroprotective functions of VEGF in those patients whose disease is unresponsive to VEGF neutralization. Copyright © 2014 Elsevier Ltd. All rights reserved.
    Trends in Molecular Medicine 11/2014; 21(1). DOI:10.1016/j.molmed.2014.10.005
  • [Show abstract] [Hide abstract]
    ABSTRACT: Leukocyte trafficking is generally considered the initial stage of any immune response, and it involves a multistep intravascular process including capture, rolling, activation, arrest, crawling, and transmigration. Both capture and rolling are predominantly mediated by selectins, which allow circulating leukocytes to sense activating signals on the endothelium and adhere to vessel walls. In this review, we discuss recent data showing that the T cell immunoglobulin and mucin domain 1 (TIM-1) protein is a major ligand for endothelial P-selectin, mediating T helper (Th) cell Th1 and Th17 trafficking in inflamed tissues. We highlight structural and functional features showing that TIM-1 can be included in the restricted group of major adhesion receptors involved in leukocyte trafficking with a pathophysiological role in inflammation and autoimmunity. Copyright © 2014 Elsevier Ltd. All rights reserved.
    Trends in Molecular Medicine 10/2014; 20(12). DOI:10.1016/j.molmed.2014.10.003
  • [Show abstract] [Hide abstract]
    ABSTRACT: The most commonly used therapies for cancer involve delivering high doses of radiation or toxic chemicals to the patient that also cause substantial damage to normal tissue. To overcome this, researchers have recently resorted to a basic biological concept called 'synthetic lethality' (SL) that takes advantage of interactions between gene pairs. The identification of SL interactions is of considerable therapeutic interest because if a particular gene is SL with a tumor-causing mutation, then the targeting that gene carries therapeutic advantages. Mapping these interactions in the context of human cancer cells could hold the key to effective, targeted cancer treatments. In this review, we cover the recent advances that aim to identify these SL interactions using unbiased genetic screens. Copyright © 2014 Elsevier Ltd. All rights reserved.
    Trends in Molecular Medicine 10/2014; 20(12). DOI:10.1016/j.molmed.2014.09.009
  • Trends in Molecular Medicine 10/2014; 20(11). DOI:10.1016/j.molmed.2014.10.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: The human hair follicle (HF) is an exquisitely hormone-sensitive mini-organ that undergoes cyclical remodeling. It is also a source and target of numerous neurohormones, neuropeptides, and neurotransmitters that regulate HF growth, pigmentation, remodeling, immune status, stem cell biology, and energy metabolism. Indeed, organ-cultured human scalp HFs can be utilized to identify ‘novel’ clinically relevant functions of major neuromediators. This is pertinently illustrated by the discoveries of: (i) thyrotropin-releasing hormone (TRH) as a hair growth and pigmentation stimulator; (ii) TRH and thyrotropin (TSH) as potent promoters of mitochondrial activity and regulators of keratin expression; and (iii) prolactin as an epithelial stem cell modulator. Thus, HF neuroendocrinology affords insights well beyond hair growth and dermatoendocrinology, uncovering new translationally relevant neuroendocrinology principles and novel therapeutic targets.
    Trends in Molecular Medicine 10/2014; 20(10). DOI:10.1016/j.molmed.2014.06.002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute respiratory infection (ARI) is a common diagnosis in outpatient and emergent care settings. Currently available diagnostics are limited, creating uncertainty in the use of antibacterial, antiviral, or supportive care. Up to 72% of ambulatory care patients with ARI are treated with an antibacterial, despite only a small fraction actually needing one. Antibiotic overuse is not restricted to ambulatory care: ARI accounts for approximately 5 million emergency department (ED) visits annually in the USA, where 52–61% of such patients receive antibiotics. Thus, an accurate test for the presence or absence of viral or bacterial infection is needed. In this review, we focus on recent research showing that the host-response (genomic, proteomic, or miRNA) can accomplish this task.
    Trends in Molecular Medicine 10/2014; 20(10). DOI:10.1016/j.molmed.2014.08.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: The inhibitor of apoptosis (IAP) family members, notably cIAP1, cIAP2, and XIAP, are critical and universal regulators of tumor necrosis factor (TNF) mediated survival, inflammatory, and death signaling pathways. Furthermore, IAPs mediate the signaling of nucleotide-binding oligomerization domain (NOD)1/NOD2 and other intracellular NOD-like receptors in response to bacterial pathogens. These pathways are important to the pathogenesis and treatment of inflammatory bowel disease (IBD). Inactivating mutations in the X-chromosome-linked IAP (XIAP) gene causes an immunodeficiency syndrome, X-linked lymphoproliferative disease type 2 (XLP2), in which 20% of patients develop severe intestinal inflammation. In addition, 4% of males with early-onset IBD also have inactivating mutations in XIAP. Therefore, the IAPs play a greater role in gut homeostasis, immunity and IBD development than previously suspected, and may have therapeutic potential.
    Trends in Molecular Medicine 10/2014; DOI:10.1016/j.molmed.2014.09.006
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neisseria meningitidis is an extracellular pathogen, which, once in the bloodstream, has the ability to form microcolonies on the apical surface of endothelia. Pathogen interaction with microvessels is mediated by bacterial type IV pili and two receptors on endothelial cells: CD147 and the β2-adrenoceptor. CD147 facilitates the adhesion of diplococci to the endothelium, whereas the β2-adrenoceptor facilitates cell signaling, and crossing of the blood–brain barrier. In this review, we discuss how meningococcal interaction with endothelial cells is responsible for the specific clinical features of invasive meningococcal infection such as meningitis, and a peripheral thrombotic/vascular leakage syndrome possibly leading to purpura fulminans.
    Trends in Molecular Medicine 10/2014; 20(10). DOI:10.1016/j.molmed.2014.08.002